Share This Post Erstellt amSeptember 11, 2017durchThomas Eigentler You are here: Knowledge Base Melanoma: Systemic treatment Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial < Back 1445534 I53MJH2E items 1 default asc 1 1 http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/ Share This Post
Erstellt amSeptember 11, 2017durchThomas Eigentler You are here: Knowledge Base Melanoma: Systemic treatment Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial < Back 1445534 I53MJH2E items 1 default asc 1 1 http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/
